Bladder Cancer. Version 3.2020

被引：452

作者：

Flaig, Thomas W. ^{[1
]}

Spiess, Philippe E. ^{[2
]}

Agarwal, Neeraj ^{[3
]}

Bangs, Rick

Boorjian, Stephen A. ^{[4
]}

Buyyounouski, Mark K. ^{[5
]}

Chang, Sam ^{[6
]}

Downs, Tracy M. ^{[7
]}

Efstathiou, Jason A. ^{[8
]}

Friedlander, Terence ^{[9
]}

Greenberg, Richard E. ^{[10
]}

Guru, Khurshid A. ^{[11
]}

Guzzo, Thomas ^{[12
]}

Herr, Harry W. ^{[13
]}

Hoffman-Censits, Jean ^{[14
]}

Hoimes, Christopher ^{[15
,16
]}

Inman, Brant A. ^{[17
]}

Jimbo, Masahito ^{[18
]}

Kader, A. Karim ^{[19
]}

Lele, Subodh M. ^{[20
]}

Michalski, Jeff ^{[21
,22
]}

Montgomery, Jeffrey S. ^{[18
]}

Nandagopal, Lakshminarayanan ^{[23
]}

Pagliaro, Lance C. ^{[4
]}

Pal, Sumanta K. ^{[24
]}

Patterson, Anthony ^{[25
]}

Plimack, Elizabeth R. ^{[10
]}

Pohar, Kamal S. ^{[26
,27
]}

Preston, Mark A. ^{[28
]}

Sexton, Wade J. ^{[2
]}

Siefker-Radtke, Arlene O. ^{[29
]}

Tward, Jonathan ^{[3
]}

Wright, Jonathan L. ^{[30
]}

Gurski, Lisa A. ^{[31
]}

Johnson-Chilla, Alyse ^{[31
]}

机构：

[1] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[4] Mayo Clin, Canc Ctr, Rochester, MN USA

[5] Stanford Canc Inst, Stanford, CA USA

[6] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[7] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[8] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[9] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[10] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[11] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[12] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[13] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[14] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[15] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[16] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[17] Duke Canc Inst, Durham, NC USA

[18] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[19] UC San Diego Moores Canc Ctr, San Diego, CA USA

[20] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[21] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[22] Washington Univ, Sch Med, St Louis, MO 14263 USA

[23] UAB, Oneal Comprehens Canc Ctr, Birmingham, AL USA

[24] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[25] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[26] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA

[27] Ohio State Univ, Comprehens Canc Ctr, Solove Res Inst, Columbus, OH 43210 USA

[28] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[29] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[30] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[31] Natl Comprehens Canc Network, Ft Washington, MD USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 03期

关键词：

BACILLUS-CALMETTE-GUERIN; METASTATIC UROTHELIAL CARCINOMA; TRANSITIONAL-CELL CARCINOMA; PHASE-II TRIAL; BAND IMAGING CYSTOSCOPY; WHITE-LIGHT CYSTOSCOPY; T1 PAPILLARY CARCINOMA; HIGH-RISK TA; HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY; REPEAT TRANSURETHRAL RESECTION;

D O I：

10.6004/jnccn.2020.0011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder cancer, treatment of non-muscle-invasive urothelial bladder cancer, and treatment of metastatic urothelial bladder cancer because important updates have recently been made to these sections. Some important updates include recommendations for optimal treatment of non-muscleinvasive bladder cancer in the event of a bacillus Calmette-Guerin (BCG) shortage and details about biomarker testing for advanced or metastatic disease. The systemic therapy recommendations for second-line or subsequent therapies have also been revised. Treatment and management of muscle-invasive, nonmetastatic disease is covered in the complete version of the NCCN Guidelines for Bladder Cancer available at NCCN.org . Additional topics covered in the complete version include treatment of nonurothelial histologies and recommendations for nonbladder urinary tract cancers such as upper tract urothelial carcinoma, urothelial carcinoma of the prostate, and primary carcinoma of the urethra.

引用

页码：329 / 354

页数：26

共 153 条

[1] Impact of multimodal treatment on survival in patients with metastatic urothelial cancer
Abe, Takashige
Shinohara, Nobuo
Harabayashi, Toru
Sazawa, Ataru
Maruyama, Satoru
Suzuki, Shin
Nonomura, Katsuya
[J]. EUROPEAN UROLOGY, 2007, 52 (04) : 1106 - 1114
[2] Signatures of mutational processes in human cancer
Alexandrov, Ludmil B.
Nik-Zainal, Serena
Wedge, David C.
Aparicio, Samuel A. J. R.
Behjati, Sam
Biankin, Andrew V.
Bignell, Graham R.
Bolli, Niccolo
Borg, Ake
Borresen-Dale, Anne-Lise
Boyault, Sandrine
Burkhardt, Birgit
Butler, Adam P.
Caldas, Carlos
Davies, Helen R.
Desmedt, Christine
Eils, Roland
Eyfjord, Jorunn Erla
Foekens, John A.
Greaves, Mel
Hosoda, Fumie
Hutter, Barbara
Ilicic, Tomislav
Imbeaud, Sandrine
Imielinsk, Marcin
Jaeger, Natalie
Jones, David T. W.
Jones, David
Knappskog, Stian
Kool, Marcel
Lakhani, Sunil R.
Lopez-Otin, Carlos
Martin, Sancha
Munshi, Nikhil C.
Nakamura, Hiromi
Northcott, Paul A.
Pajic, Marina
Papaemmanuil, Elli
Paradiso, Angelo
Pearson, John V.
Puente, Xose S.
Raine, Keiran
Ramakrishna, Manasa
Richardson, Andrea L.
Richter, Julia
Rosenstiel, Philip
Schlesner, Matthias
Schumacher, Ton N.
Span, Paul N.
Teague, Jon W.
[J]. NATURE, 2013, 500 (7463) : 415 - +
[3] American Urological Association, 2016, DIAGNOSIS TREATMENT
[4] Amin MB., 2017, AJCC cancer staging manual, V8th, DOI [10.1007/978-3-319-40618-3, DOI 10.1007/978-3-319-40618-3]
[5] Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Antoni, Sebastien
Ferlay, Jacques
Soerjomataram, Isabelle
Znaor, Ariana
Jemal, Ahmedin
Bray, Freddie
[J]. EUROPEAN UROLOGY, 2017, 71 (01) : 96 - 108
[6] Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Apolo, Andrea B.
Infante, Jeffrey R.
Balmanoukian, Ani
Patel, Manish R.
Wang, Ding
Kelly, Karen
Mega, Anthony E.
Britten, Carolyn D.
Ravaud, Alain
Mita, Alain C.
Safran, Howard
Stinchcombe, Thomas E.
Srdanov, Marko
Gelb, Arnold B.
Schlichting, Michael
Chin, Kevin
Gulley, James L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2117 - +
[7] First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Balar, Arjun V.
Castellano, Daniel
O'Donnell, Peter H.
Grivas, Petros
Vuky, Jacqueline
Powles, Thomas
Plimack, Elizabeth R.
Hahn, Noah M.
de Wit, Ronald
Pang, Lei
Savage, Mary J.
Perini, Rodolfo F.
Keefe, Stephen M.
Bajorin, Dean
Bellmunt, Joaquim
[J]. LANCET ONCOLOGY, 2017, 18 (11) : 1483 - 1492
[8] Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Balar, Arjun V.
Galsky, Matthew D.
Rosenberg, Jonathan E.
Powles, Thomas
Petrylak, Daniel P.
Bellmunt, Joaquim
Loriot, Yohann
Necchi, Andrea
Hoffman-Censits, Jean
Perez-Gracia, Jose Luis
Dawson, Nancy A.
van der Heijden, Michiel S.
Dreicer, Robert
Srinivas, Sandy
Retz, Margitta M.
Joseph, Richard W.
Drakaki, Alexandra
Vaishampayan, Ulka N.
Sridhar, Srikala S.
Quinn, David I.
Duran, Ignacio
Shaffer, David R.
Eigl, Bernhard J.
Grivas, Petros D.
Yu, Evan Y.
Li, Shi
Kadel, Edward E., III
Boyd, Zachary
Bourgon, Richard
Hegde, Priti S.
Mariathasan, Sanjeev
Thastrom, AnnChristine
Abidoye, Oyewale O.
Fine, Gregg D.
Bajorin, Dean F.
[J]. LANCET, 2017, 389 (10064) : 67 - 76
[9] BALAR AV, 2019, J CLIN ONCOL S, V37
[10] Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guerin
Bandari, Jathin
Maganty, Avinash
MacLeod, Liam C.
Davies, Benjamin J.
[J]. EUROPEAN UROLOGY FOCUS, 2018, 4 (04): : 481 - 484

← 1 2 3 4 5 6 7 8 9 10 →